Breaking News

OctoPlus Wins Drug Delivery Contract

OctoPlus N.V. signed a new drug delivery technology evaluation contract with an undisclosed European biotech company.

OctoPlus N.V. signed a new drug delivery technology evaluation contract with an undisclosed European biotech company. This is the seventh client for which OctoPlus will work on a controlled release formulation.

Under the contract, OctoPlus will evaluate the feasibility of a controlled release formulation that combines the client’s active ingredient with OctoPlus’ drug delivery technology. If the evaluation is successful, the contract may progress to a full process development, manufacturing and licensing agreement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters